Dedhiya; Mahendra G.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dedhiya; Mahendra G..The latest application filed is for "modified release formulations of memantine oral dosage forms".

Company Profile

4.28.66

Dedhiya; Mahendra G. - Pomona NY
Dedhiya; Mahendra G - Pomona NY
Dedhiya; Mahendra G - Doublin OH
Dedhiya, Mahendra G. - Doublin OH
Dedhiya; Mahendra G. - Dublin OH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical formulations containing dopamine receptor ligands Grant RE49,110 - Sarkar , et al. June 21, 2	2022-06-21
Modified Release Formulations Of Memantine Oral Dosage Forms App 20200268685 - Rastogi; Suneel K. ; et al.	2020-08-27
Modified release formulations of memantine oral dosage forms Grant 10,660,868 - Rastogi , et al.	2020-05-26
Pharmaceutical formulations containing dopamine receptor ligands Grant RE47,350 - Sarkar , et al.	2019-04-16
Pharmaceutical formulations containing dopamine receptor ligands Grant RE47,333 - Sarkar , et al.	2019-04-02
Donepezil Compositions And Methods Of Treating Alzheimers Disease App 20180169082 - Dedhiya; Mahendra G. ; et al.	2018-06-21
Novel Crystalline Forms Of Trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide Sodium Salt App 20170210742 - Dedhiya; Mahendra G. ; et al.	2017-07-27
Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof Grant 9,695,122 - Ronsheim , et al. July 4, 2	2017-07-04
Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt Grant 9,580,424 - Dedhiya , et al. February 28, 2	2017-02-28
Processes For Preparing Heterocyclic Compounds Including Trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide And Salts Thereof App 20170022160 - Ronsheim; Melanie Simone ; et al.	2017-01-26
Modified Release Formulations Of Memantine Oral Dosage Forms App 20160324803 - Rastogi; Suneel K. ; et al.	2016-11-10
Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof Grant 9,284,314 - Ronsheim , et al. March 15, 2	2016-03-15
Crystalline forms of (1S,2R)-2-(amino methyl)-N,N-diethyl-1-phenyl cyclopropane carboxamide Grant 9,259,403 - Surana , et al. February 16, 2	2016-02-16
Stable Glucokinase Activator Compositions App 20160015638 - Mo; Yun ; et al.	2016-01-21
Modified Release Formulations Of Memantine Oral Dosage Forms App 20150258031 - RASTOGI; Suneel K. ; et al.	2015-09-17
Modified And Immediate Release Formulations Of Memantine App 20150258042 - DEDHIYA; Mahendra G. ; et al.	2015-09-17
Novel Crystalline Forms Of Trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide Sodium Salt App 20150246920 - Dedhiya; Mahendra G. ; et al.	2015-09-03
Orally Dissolving Formulations of Memantine App 20150238442 - Mahashabde; Shashank ; et al.	2015-08-27
Donepezil Compositions And Methods Of Treating Alzheimers Disease App 20150216849 - Dedhiya; Mahendra G. ; et al.	2015-08-06
Soluble Dosage Forms Containing Cephem Derivatives Suitable For Parenteral Administration App 20150196572 - Dedhiya; Mahendra G. ; et al.	2015-07-16
Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-Diazabicyclo[3,2,1]octane-2-carboxamide sodium salt Grant 9,062,053 - Dedhiya , et al. June 23, 2	2015-06-23
Pharmaceutical formulations containing dopamine receptor ligands Grant 9,056,846 - Sarkar , et al. June 16, 2	2015-06-16
Pharmaceutical formulations containing dopamine receptor ligands Grant 9,056,845 - Sarkar , et al. June 16, 2	2015-06-16
Chemical Composition App 20150148388 - Chhettry; Anil ; et al.	2015-05-28
Modified Release Formulations Of Memantine Oral Dosage Forms App 20150148427 - RASTOGI; Suneel K. ; et al.	2015-05-28
Compositions And Methods Of Treatment Comprising Fosfomycin Disodium App 20150132382 - Dedhiya; Mahendra G. ; et al.	2015-05-14
Processes For Preparing Heterocyclic Compounds Including Trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide And Salts Thereof App 20150112070 - Ronsheim; Melanie Simone ; et al.	2015-04-23
Orally Dissolving Formulations of Memantine App 20150065582 - Mahashabde; Shashank ; et al.	2015-03-05
Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof Grant 8,969,566 - Ronsheim , et al. March 3, 2	2015-03-03
Novel Crystalline Forms Of (1s,2r)-2-(amino Methyl)-n,n-diethyl-1-phenyl Cyclopropane Carboxamide App 20150038587 - Surana; Rahul ; et al.	2015-02-05
Compositions Comprising Cyclohexylamines And Aminoadamantanes App 20140350114 - DEDHIYA; Mahendra G. ; et al.	2014-11-27
Novel Crystalline Forms Of Trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide Sodium Salt App 20140349967 - Dedhiya; Mahendra G. ; et al.	2014-11-27
Immediate Release Formulations Of 1-aminocyclohexane Compounds, Memantine And Neramexane App 20140348932 - YANG; Yan ; et al.	2014-11-27
Crystalline forms of (1S,2R)-2-(amino methyl)-N,N-diethyl-1-phenyl cyclopropane carboxamide Grant 8,865,937 - Dedhiya , et al. October 21, 2	2014-10-21
Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt Grant 8,835,455 - Dedhiya , et al. September 16, 2	2014-09-16
Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane Grant 8,834,924 - Yang , et al. September 16, 2	2014-09-16
Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof Grant 8,829,191 - Ronsheim , et al. September 9, 2	2014-09-09
Modified Release Formulations Of Memantine Oral Dosage Forms App 20140213659 - RASTOGI; Suneel K. ; et al.	2014-07-31
Processes For Preparing Heterocyclic Compounds Including Trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide And Salts Thereof App 20140163230 - Ronsheim; Melanie Simone ; et al.	2014-06-12
Chemical Composition App 20140057954 - Chhettry; Anil ; et al.	2014-02-27
Milnacipran Formulations App 20140023710 - Dedhiya; Mahendra G. ; et al.	2014-01-23
Modified Release Formulations Of Memantine Oral Dosage Forms App 20130310460 - RASTOGI; Suneel K. ; et al.	2013-11-21
Modified And Immediate Release Formulations Of Memantine App 20130302430 - DEDHIYA; Mahendra G. ; et al.	2013-11-14
Novel Crystalline Forms Of Trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide Sodium Salt App 20130267480 - Dedhiya; Mahendra G. ; et al.	2013-10-10
Novel Crystalline Forms Of (1s,2r)-2-(amino Methyl)-n,n-diethyl-1-phenyl Cyclopropane Carboxamide App 20130210919 - Surana; Rahul ; et al.	2013-08-15
Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt Grant 8,471,025 - Dedhiya , et al. June 25, 2	2013-06-25
Pharmaceutical Formulations Containing Dopamine Receptor Ligands App 20130040966 - SARKAR; Ranajoy ; et al.	2013-02-14
Modified And Immediate Release Formulations Of Memantine App 20130011474 - DEDHIYA; Mahendra G. ; et al.	2013-01-10
Modified Release Formulations Of Memantine Oral Dosage Forms App 20130012593 - Rastogi; Suneel K. ; et al.	2013-01-10
Processes For Preparing Heterocyclic Compounds Including Trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide And Salts Thereof App 20120323010 - Ronsheim; Melanie Simone ; et al.	2012-12-20
Compositions Comprising Cyclohexylamines And Aminoadamantanes App 20120238631 - Dedhiya; Mahendra G. ; et al.	2012-09-20
Cephem compounds useful for the treatment of bacterial infections Grant 8,247,400 - Dedhiya , et al. August 21, 2	2012-08-21
Modified And Immediate Release Formulations Of Memantine App 20120201889 - Dedhiya; Mahendra G. ; et al.	2012-08-09
Soluble Dosage Forms Containing Cephem Derivatives Suitable For Parenteral Administration App 20120010180 - Dedhiya; Mahendra G. ; et al.	2012-01-12
Modified Release Formulations Of Memantine Oral Dosage Forms App 20120004318 - Rastogi; Suneel K. ; et al.	2012-01-05
Modified release formulations of memantine oral dosage forms Grant 8,039,009 - Rastogi , et al. October 18, 2	2011-10-18
Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane App 20110236439 - Yang; Yan ; et al.	2011-09-29
Memantine Formulations App 20110165252 - DEDHIYA; Mahendra G. ; et al.	2011-07-07
Novel Crystalline Forms Of Trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide Sodium Salt App 20110152311 - Dedhiya; Mahendra G. ; et al.	2011-06-23
Novel Crystalline Forms Of (1s,2r)-2-(amino Methyl)-n,n-diethyl-1-phenyl Cyclopropane Carboxamide App 20110112197 - Dedhiya; Mahendra G. ; et al.	2011-05-12
Orally Dissolving Formulations of Memantine App 20110046232 - Mahashabde; Shashank ; et al.	2011-02-24
Milnacipran Formulations App 20100286260 - Dedhiya; Mahendra G. ; et al.	2010-11-11
Novel Cephem Compounds Useful For The Treatment Of Bacterial Infections App 20100216745 - Dedhiya; Mahendra G. ; et al.	2010-08-26
Methods Of Managing Fibromyalgia Using Milnacipran App 20100197797 - Rao; Srinivas G. ; et al.	2010-08-05
Compositions comprising Cyclohexylamines and Aminoadamantanes App 20100035995 - Dedhiya; Mahendra G. ; et al.	2010-02-11
Immediate Release Formulations Of 1-aminocyclohexane Compounds, Memantine And Neramexane App 20100028427 - Yang; Yan ; et al.	2010-02-04
Pharmaceutical Formulations Containing Dopamine Receptor Ligands App 20100016334 - SARKAR; Ranajoy ; et al.	2010-01-21
Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent Grant 7,648,696 - McPhillips , et al. January 19, 2	2010-01-19
Memantine Formulations App 20090247644 - DEDHIYA; Mahendra G. ; et al.	2009-10-01
Bioavailable Formulations Of Heterocyclic Compounds App 20080194638 - DEDHIYA; Mahendra G. ; et al.	2008-08-14
Orally Dissolving Formulations of Memantine App 20080008743 - Dedhiya; Mahendra G. ; et al.	2008-01-10
Compositions Comprising Cyclohexylamines and Aminoadamantanes App 20070270500 - Dedhiya; Mahendra G. ; et al.	2007-11-22
Modified And Pulsatile Release Pharmaceutical Formulations Of Escitalopram App 20070134322 - Dedhiya; Mahendra G. ; et al.	2007-06-14
Pharmaceutical formulations comprising ibuprofen, oxycodone, and 14-hydroxycodeinone App 20070117826 - Janjikhel; Rajiv ; et al.	2007-05-24
Stable pharmaceutical formulations containing escitalopram and bupropion App 20070112075 - Dedhiya; Mahendra G. ; et al.	2007-05-17
Modified And Immediate Release Formulations Of Memantine App 20070065512 - Dedhiya; Mahendra G. ; et al.	2007-03-22
Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane App 20060198884 - Yang; Yan ; et al.	2006-09-07
Lercanidipine modified release compositions App 20060165789 - Abramowitz; Wattanaporn ; et al.	2006-07-27
Lercanidipine pH dependent pulsatile release compositions App 20060165788 - Abramowitz; Wattanaporn ; et al.	2006-07-27
Lercanidipine immediate release compositions App 20060134212 - Dedhiya; Mahendra G. ; et al.	2006-06-22
Modified release formulations of memantine oral dosage forms App 20060051416 - Rastogi; Suneel K. ; et al.	2006-03-09
Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane App 20060002999 - Yang; Yan ; et al.	2006-01-05
Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent App 20040162336 - McPhillips, Andrea M. ; et al.	2004-08-19
Stable composition for inhalation therapy comprising delta-9-tetrahydrocannabinol and semiaqueous solvent therefor Grant 6,747,058 - Dedhiya , et al. June 8, 2	2004-06-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.